| Schedule of Earnings Per Share, Basic and Diluted |
The following table provides a reconciliation of the numerator and the denominator used in computing basic and diluted earnings per share attributable to common stockholders (in thousands, except net earnings per share data): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30, | | September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Numerator for basic earnings per share: | | | | | | | | | Net income (loss) attributable to common stockholders | $ | 250,271 | | | $ | (23,093) | | | $ | 517,214 | | | $ | (89,526) | | Net income (loss), numerator—basic | $ | 250,271 | | | $ | (23,093) | | | $ | 517,214 | | | $ | (89,526) | | | | | | | | | | | Numerator for diluted earnings per share: | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30, | | September 30, | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | Net income (loss) attributable to common stockholders | $ | 250,271 | | | $ | (23,093) | | | $ | 517,214 | | | $ | (89,526) | | | Add: debt interest cost, net of taxes | 3,534 | | | — | | | 12,169 | | | — | | Net income (loss), numerator—diluted | $ | 253,805 | | | $ | (23,093) | | | $ | 529,383 | | | $ | (89,526) | | | | | | | | | | | Denominator for basic earnings per share: | | | | | | | | | Weighted average common shares outstanding | 294,757 | | | 234,931 | | | 287,970 | | | 232,579 | | | | | | | | | | | Denominator for diluted earnings per share: | | | | | | | | Weighted average common shares outstanding—basic | 294,757 | | | 234,931 | | | 287,970 | | | 232,579 | | | Effect of dilutive securities: | | | | | | | | | Convertible notes | 13,922 | | | — | | | 18,250 | | | — | | Warrant (Note 3) | — | | | — | | | 141 | | | — | | | Stock options and awards | 15,610 | | | — | | | 16,946 | | | — | | Weighted average common shares outstanding—diluted | 324,289 | | | 234,931 | | | 323,307 | | | 232,579 | | | | | | | | | | | Net earnings per share available to common stockholders: | | | | | | | | | Basic | $ | 0.85 | | | $ | (0.10) | | | $ | 1.80 | | | $ | (0.38) | | | Diluted | $ | 0.78 | | | $ | (0.10) | | | $ | 1.64 | | | $ | (0.38) | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share |
The following common stock equivalents were excluded from the computation of our earnings per share available to common stockholders, diluted, for the three and nine months ended September 30, 2025, as their inclusion would have been antidilutive (in thousands): | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | | | 2025 | | 2025 | | | | | | Convertible notes | 62,029 | | | 59,206 | | | Stock options and awards | 15,519 | | | 16,048 | | | 77,548 | | | 75,254 | |
|